Valneva has announced that it is in ‘active discussions’ with a prospective partner for potentially funding the development of a second-generation COVID-19 vaccine that targets new variants of the virus.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,